FIELD: chemistry.
SUBSTANCE: group of inventions relates to organic chemistry and includes compounds: (Z)-3-((3-butyl-3-methyl-7-(methylthio)-1,1-dioxide-5-phenyl-2,3,4,5-tetrahydro-1,5-benzothiazepine-8-yl)oxy)-2-fluoroacrylic acid, (R)-(Z)-3-((3-butyl-3-methyl-7-(methylthio)-1,1-dioxide-5-phenyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-8-yl)oxy)-2-fluoroacrylic acid, (S)-(Z)-3-((3-butyl-3-methyl-7-(methylthio)-1,1-dioxide-5-phenyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-8-yl)oxy)-2-fluoroacrylic acid, (E)-3-((3-methyl-7-(methylthio)-1,1-dioxide-5-phenyl-3-propyl-2,3,4,5-tetrahydro-1,5-benzothiazepine-8-sludge)oxy)acrylic acid, (S)-(E)-3-((3-methyl-7-(methylthio)-1,1-dioxide-5-phenyl-3-propyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-8-yl)oxy)acrylic acid, (R)-(E)-3-((3-methyl-7-(methylthio)-1,1-dioxide-5-phenyl-3-propyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-8-yl)oxy)acrylic acid, (Z)-2-fluoro-3-((3-methyl-7-(methylthio)-1,1-dioxide-5-phenyl-3-propyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-8-yl)oxy)acrylic acid, (R)-(Z)-2-fluoro-3-((3-methyl-7-(methylthio)-1,1-dioxide-5-phenyl-3-propyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-8-yl)oxy)acrylic acid, (S)-(Z)-2-fluoro-3-((3-methyl-7-(methylthio)-1,1-dioxide-5-phenyl-3-propyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-8-yl)oxy)acrylic acid, (Z)-3-((3-ethyl-3-methyl-7-(methylthio)-1,1-dioxide-5-phenyl-2,3,4,5-tetrahydro-1,5-benzothiazepine-8-yl)oxy)-2-fluoroacrylic acid, pharmaceutically acceptable salts thereof, a pharmaceutical composition based thereon and use.
EFFECT: technical result is 1,5-benzothiazepine derivatives possessing activity of inhibition of apical sodium-dependent bile acid transporter (ASBT) and/or liver bile acid transporter (LBAT).
7 cl, 1 dwg, 8 tbl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
BENZOTHIAZEPINE COMPOUNDS AND USE THEREOF AS BILE ACID MODULATORS | 2020 |
|
RU2838460C1 |
BENZOTHIA(DI)AZEPINE COMPOUNDS AND USE THEREOF AS BILE ACID MODULATORS | 2021 |
|
RU2841263C1 |
BENZOTHIA(DI)AZEPINE COMPOUNDS AND USE THEREOF AS BILE ACID MODULATORS | 2020 |
|
RU2827704C1 |
BENZOTHIA (DI) AZEPINE COMPOUNDS AND USE THEREOF AS BILE ACID MODULATORS | 2020 |
|
RU2838220C1 |
BENZOTHIAZEPINE COMPOUNDS AND USE THEREOF AS BILE ACID MODULATORS | 2020 |
|
RU2817535C2 |
BENZOTHIADIAZEPINE COMPOUNDS AND USE THEREOF AS BILE ACID MODULATORS | 2020 |
|
RU2838136C1 |
BENZOTHIADIAZEPINE COMPOUNDS AND THEIR USE AS BILE ACIDS MODULATORS | 2020 |
|
RU2814570C2 |
BENZOTHIA(DI)AZEPINES AND THEIR USE AS BILE ACID MODULATORS | 2019 |
|
RU2785867C2 |
PHARMACEUTICAL COMBINATION COMPRISING IBAT-INHIBITOR AND BILE ACID BINDER | 2011 |
|
RU2619215C2 |
1,5-BENZOTHIAZEPINES AND EMPLOYMENT THEREOF AS ANTIHYPERLIPIDEMIC DRUGS | 2001 |
|
RU2302414C2 |
Authors
Dates
2025-04-07—Published
2020-12-04—Filed